Registration, storage and distribution of chemicals and drugs for pre-clinical discovery evaluation and development
Ended Awarded
- Contract number
- HHSN26100003
- Awardee
-
Fisher Bioservices Inc. UEI LB4PCGLSJ9E6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $78,987
Award facts
- Opportunity
-
- N02CO5700594 Solicitation number
- Registration, Storage and Distribution of Chemicals and Drugs for Pre-Clinical Discovery Evaluation and Development Award Notice · Posted Mar 2, 2016
- Registration, Storage and Distribution of Chemicals and Drugs for Pre-Clinical Discovery Evaluation and Development Award Notice · Posted Sep 18, 2015
- Registration, Storage and Distribution of Chemicals and Drugs for Pre-Clinical Discovery Evaluation and Development Award Notice · Posted Jun 23, 2015
- Contract value 100% obligated
- $78,987.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- S215 Housekeeping- Warehousing/Storage
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award from the National Cancer Institute (NCI), a civilian agency, to Fisher Bioservices Inc.'s Clinical Trials Division, a subsidiary of Thermo Electron Corporation. The contract is for the registration, storage, and distribution of chemicals and drugs for pre-clinical discovery evaluation and development, with a ceiling value of $78,987.04.
The contract is a delivery order under a larger indefinite delivery vehicle (IDV) contract valued at $19 million, which involves operating and maintaining the NCI's Chemotherapeutic Agents Repository. Fisher Bioservices has extensive experience as both a prime contractor and subcontractor on federal contracts supporting biomedical research and public health initiatives for agencies such as the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Department of Defense (DoD). This contract does not have a set-aside designation.
Quick answers
Who was awarded contract HHSN26100003?
HHSN26100003 was awarded to Fisher Bioservices Inc. by National Cancer Institute (National Institutes of Health) on May 26, 2017.
How much is contract HHSN26100003 worth?
The government has obligated $78,987 on HHSN26100003.
Is contract HHSN26100003 an order under another contract?
Yes. HHSN26100003 is a delivery order under HHSN261201600006I, an indefinite delivery contract.
Was contract HHSN26100003 competed?
The extent of competition for HHSN26100003 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award